Soluble Expression, Protein Purification and Quality Control of Recombinant Porcine Interferon-α
Bu sunuda rekombinant domuz interferon alfa (rPoIFN-?)'nın Escherichia coli-temelli ekspresyonu ve saflaştırma metodu rapor edilmiştir. PoIFN-? kodlayan sekansı pMD18-T vektör içine klonlandı ve sonrasında standart rekombinant DNA teknikleri kullanılarak pET-32a (+) vektör içine subklonlandı ve elde edilen plazmid BL21(DE3) kompetan hücreler içine nakledildi. İzopropil-?-D-1-tiogalaktopiyranosid (IPTG) ile uyarmanın ardından rPoIFN-?, bakteri lizatının süpernatantından basit iki basamaklı kromatografi işlemi (Ni2+ affinite kromatografi ve DEAE anyon değişim kromatografi) kullanılarak saflaştırıldı. rPoIFN-? 48 mg/L kültür oluşumu ve >95% homojenite ile saflaştırıldı. Ürün 6.09 izoelektrik puanına sahip olup bakteriyal endotoksin 1 EU/mg'dan daha azd?. N-ucu amino asit sekans? ve tripsin ile olu?turulan peptit haritas? rPoIFN-?'nın özgünlüğü hakkında ilave kan?t sa?lad?. rPoIFN-?'nın biyolojik aktivitesi HEp-2/ Vesicular Stomatitis Virus (VSV) titrasyon sisteminde 1.1×106 IU/mL olarak tespit edilirken spesifik aktivitesi 1.0×106 IU/mg'a ulaştı. Sonuç olarak, pET-32a (+) prokaryotik ekspresyon sistemi kullanılarak biyoaktif rPoIFN-?'nın çözünür formunun yüksek derecede ekspresyonu sağlandı
Rekombinant Domuz İnterferon-α’nın Çözünür Ekspresyonu, Protein Saflaştırması ve Kalite Kontrolü
Herein, we reported an Escherichia coli-based expression and purification method of recombinant porcine interferon alpha (rPoIFN-α). PoIFN-α coding sequence was cloned into pMD18-T vector and then subcloned into pET-32a (+) vector using standard recombinant DNA techniques and the resulting plasmid was transformed into BL21(DE3) competent cells. After induction with isopropyl-β-D-1-thiogalactopyranoside (IPTG), rPoIFN-α was purified from the supernatant of the bacteria lysate using a simple two-step chromatography process consisting of a Ni2+affinity chromatography and a DEAE anion exchange chromatography. rPoIFN-α was purified to >95% homogeneity with a yield of 48 mg/L of culture. It has isoelectic point of 6.09 and bacterial endotoxin was less than 1 EU/mg. N-terminal amino acid sequence and the peptide map digested by trypsin provided additional evidence for the authenticity of rPoIFN-α. The biological activity of rPoIFN-α was 1.1×106 IU/mL in HEp-2/ Vesicular Stomatitis Virus (VSV) titration system and its specific activity reached to 1.0×106 IU/mg. In conclusion, we obtained high-level expression of a soluble form of bioactive rPoIFN-α by using pET-32a (+) prokaryotic expression system
___
- 1. Taylor KE, Mossman KL: Recent advances in understanding viral evasion of type I interferon. Immunology, 138, 190-197, 2013. DOI: 10.1111/imm.12038
- 2. Wang YB, Wang ZY, Chen HY, Cui BA, Wang YB, Zhang HY, Wang R: Secretory expression of porcine interferon-gamma in baculovirus using HBM signal peptide and its inhibition activity on the replication of porcine reproductive and respiratory syndrome virus.Vet Immunol Immunopathol, 132, 314-317, 2009. DOI: 10.1016/j.vetimm.2009.05.017
- 3. Lefèvre F, L’Haridon R, Borras-Cuesta F, La Bonnardière C: Production, purification and biological properties of an Escherichia coliderived recombinant porcine alpha interferon. J Gen Virol, 71, 1057-1063, 1990. DOI: 10.1099/0022-1317-71-5-1057
- 4. Yu R, Dong S, Zhu Y, Jin H, Gao M, Duan Z, Zheng Z, Shi Z, Li Z: Effective and stable porcine interferon-alpha production by Pichia pastoris fed-batch cultivation with multi-variables clustering and analysis. Bioprocess Biosyst Eng, 33, 473-483, 2010. DOI: 10.1007/s00449- 009-0356-3
- 5. Liu ZQ, Yang PC: Construction of pET-32 α (+) Vector for Protein Expression and Purification. N Am J Med Sci, 4, 651-655, 2012. DOI: 10.4103/1947-2714.104318
- 6. Kruger NJ: The Bradford method for protein quantitation. Methods Mol Biol, 32, 9-15, 1994. DOI: 10.1385/0-89603-268-X:9
- 7. Armstrong JA: Cytopathic effect inhibition assay for interferon: Microculture plate assay. Methods Enzymol, 78, 381-387, 1981. DOI: 10.1016/0076-6879(81)78145-X
- 8. Reed LJ, Muench H: A simple method of estimating 50 percent end points. Am J Hyg, 27, 493-497, 1938. DOI: 10.1093/oxfordjournals.aje.a118408
- 9. Commission of Chinese Veterinary Pharmacopoeia: Veterinary Pharmacopeia of the People’s Republic of China. 2010 edn., Part I, Appendix 26-130, China Agriculture Press, Beijing, 2010.